| 1 | Longitudinal Changes in Mitochondrial DNA Copy Number and Telomere Length in Patients with Parkinson?s Disease | 1ᵉʳ autor: Ortega-Vázquez A., Sánchez-Badajos S., Ramírez-García M.Á., Alvarez-Luquín D., et al. | 2023 | GENES | WoS-id: 001099286300001
Scopus-id: 2-s2.0-85175279429
| 4 | 6 |
| 2 | Relationship between APOE, PER2, PER3 and OX2R Genetic Variants and Neuropsychiatric Symptoms in Patients with Alzheimer?s Disease | Coautor: Ortega-Vázquez A., Lozano-Tovar S., Rodríguez-Agudelo Y., Dávila-Ortiz de Montellano D.J., et al. | 2023 | INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH | Scopus-id: 2-s2.0-85149793827
| 0 | 4 |
| 3 | The role of alcohol intake in the pharmacogenetics of treatment with clozapine | Coautor: Ortega-Vázquez A., Monroy-Jaramillo N., Martínez-Magaña J.J., Pérez-Aldana B.E., et al. | 2022 | Pharmacogenomics | WoS-id: 000771718100001
Scopus-id: 2-s2.0-85128396262
| 3 | 3 |
| 4 | Clozapine Long-Term Treatment Might Reduce Epigenetic Age Through Hypomethylation of Longevity Regulatory Pathways Genes | Coautor: Ortega-Vázquez A., Pérez-Aldana B.E., Martínez-Magaña J.J., Mayén-Lobo Y.G., et al. | 2022 | Frontiers in Psychiatry | WoS-id: 000806123100001
Scopus-id: 2-s2.0-85131601297
| 3 | 3 |
| 5 | Alcohol intake potentiates clozapine adverse effects associated to CYP1A2*1C in patients with refractory psychosis | 1ᵉʳ autor: Ortega-Vázquez A., Mayen-Lobo Y.G., Dávila-Ortiz de Montellano D.J., Tristán-López L., et al. | 2021 | DRUG DEVELOPMENT RESEARCH | WoS-id: 000599520400001
Scopus-id: 2-s2.0-85097666570
| 5 | 5 |
| 6 | Integrative genomic?epigenomic analysis of clozapine-treated patients with refractory psychosis | Coautor: Ortega-Vázquez A., Mayén-Lobo Y.G., Martínez-Magaña J.J., Pérez-Aldana B.E., et al. | 2021 | Pharmaceuticals | WoS-id: 000622885400001
Scopus-id: 2-s2.0-85100802082
| 9 | 9 |
| 7 | Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy | 1ᵉʳ autor: Ortega-Vázquez A., Fricke-Galindo I., Dorado P., Jung-Cook H., et al. | 2020 | PHARMACOGENOMICS JOURNAL | WoS-id: 000537022300001
Scopus-id: 2-s2.0-85085899958
| 11 | 11 |
| 8 | High prevalence of CYP2D6 ultrarapid metabolizers in a mestizo Colombian population in relation to Hispanic mestizo populations | Coautor: Ortega-Vazquez, Alberto, Sarmiento, Alba P., Dorado, Pedro, Borbon, Angelica, et al. | 2020 | Pharmacogenomics | WoS-id: 000584494200001
Scopus-id: 2-s2.0-85096947039
| 0 | 1 |
| 9 | STRA6 Polymorphisms Are Associated With EGFR Mutations in Locally-Advanced and Metastatic Non-Small Cell Lung Cancer Patients | Coautor: Ortega A., Muñiz-Hernández S., Velázquez-Fernández J.B., Díaz-Chávez J., et al. | 2020 | Frontiers in Oncology | WoS-id: 000596557100001
Scopus-id: 2-s2.0-85097414242
| 9 | 9 |
| 10 | Niemann-Pick disease A or B in four pediatric patients and SMPD1 mutation carrier frequency in the Mexican population | Coautor: Ortega-Vazquez, Alberto, Ceron-Rodriguez, Magdalena, Vázquez-Martínez E.R., Garcia-Delgado, Constanza, et al. | 2019 | Annals Of Hepatology | WoS-id: 000483461300014
Scopus-id: 2-s2.0-85069235758
| 9 | 11 |
| 11 | Interethnic variability in CYP2D6, CYP2C9, and CYP2C19 genes and predicted drug metabolism phenotypes among 6060 ibero-and native Americans: RIBEF-CEIBA consortium report on population pharmacogenomics | Coautor: Ortega-Vázquez A., Naranjo M.-E.G., Rodrigues-Soares F., Peñas-Lledó E.M., et al. | 2018 | OMICS | WoS-id: 000444386700001
Scopus-id: 2-s2.0-85053861167
| 30 | 37 |
| 12 | Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms | Coautor: Ortega-Vázquez A., Favela-Mendoza A.F., Rangel-Villalobos H., Fricke-Galindo I., et al. | 2018 | MOLECULAR BIOLOGY REPORTS | WoS-id: 000452543200092
Scopus-id: 2-s2.0-85055248430
| 9 | 9 |